ArticlePediatric blood & cancer2012

Initial testing (stage 1) of the cyclin dependent kinase inhibitor SCH 727965 (dinaciclib) by the pediatric preclinical testing program.

Richard Gorlick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.